{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:53Z","timestamp":1760264813571},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4715,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1995,8]]},"abstract":"<jats:p>Previously, we have shown the ability to induce experimental autoimmune conditions (e. g. SLE, APLS, Wegener's granulomatosis) following active immunization with the pathogenic autoantibody emulsified in adjuvant. The mice first develop anti\u2010autoantibodies (Ab<jats:sub>2<\/jats:sub>: anti\u2010id) and eventually generate anti\u2010anti\u2010autoantibodies (Ab<jats:sub>3<\/jats:sub>: anti\u2010anti\u2010id) which carry the same antigen binding characteristic as the autoantibody (Ab<jats:sub>1<\/jats:sub>), The appearance of the specific autoantibodies in mice sera was associated with the emergence of the compatible laboratory and with the clinical findings characteristic to the respective autoimmune disease. The effects of syngeneic bone marrow transplantation (BMT) on experimental anti\u2010phospholipid syndrome (APS) were investigated. BALB\/c mice were immunized with anti\u2010cardiolipin monoclonal antibody (MoAb) named CAM and developed elevated serum titres of anti\u2010phospholipid Abs accompanied by prolonged activated partial thromboplastin time, thrombocytopenia and a high percentage of fetal resorptions. These mice were then lethally irradiated and transfused with bone marrow (BM) cells (T cell depleted) from syngeneic naive mice. The titres of antiphospholipid antibodies were reduced in the recipients. The decrease in titre of autoantibodies was found to be related to depletion of antibody forming cells <jats:italic>in vivo<\/jats:italic>, associated with reduced proliferative response of lymph node cells to anti\u2010cardiolipin MoAbs. The recipients showed improvement in clinical parameters following syngeneic BMT. The same recipients developed specific unresponsiveness to a second challenge with the anticardiolipin MoAb (CAM), but developed experimental systemic lupus erythe\u2010matosus upon immunization with a monoclonal anti\u2010DNA antibody. We conclude that acute myeloablative immunosuppression combined with syngeneic bone marrow transplantation may induce a state of tolerance to the pathogenic autoantibodies in mice with experimental APLS. Our results suggest that a similar approach may be useful in treating life\u2010threatening autoimmune syndromes (e. g. catastrophic APLS) in clinical practice.<\/jats:p>","DOI":"10.1111\/j.1365-3083.1995.tb03649.x","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T03:52:28Z","timestamp":1151725948000},"page":"226-234","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Induction of Tolerance to Experimental Anti\u2010Phospholipid Syndrome (APS) by Syngeneic Bone Marrow Cell Transplantation"],"prefix":"10.1111","volume":"42","author":[{"given":"M.","family":"BLANK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"TOMER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"SLAVIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"SHOENFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91267-9"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.62.734.1081"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507183130304"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115749"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(92)90008-E"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)90700-5"},{"key":"e_1_2_2_8_2","first-page":"630","article-title":"Heparin therapy for pregnant woman with lupus anti\u2010coagulant and anticardiolipin antibodies","volume":"75","author":"Rosove MH","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.10.798"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92584-0"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92859-0"},{"key":"e_1_2_2_12_2","first-page":"423","article-title":"Prevention of fetal loss in experimental anti\u2010phospholipid syndrome by low molecular weight heparin","volume":"169","author":"Inbar O","year":"1993","journal-title":"Am J Reprod Immunol"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1993.tb00581.x"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116396"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.6.1693"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116648"},{"key":"e_1_2_2_17_2","first-page":"78","article-title":"Successful treatment of autoimmunity in MRL\/lpr mice with T\u2010cell depleted syngeneic bone marrow transplantation","volume":"13","author":"Karussis DM","year":"1993","journal-title":"J Immunol Immunopharmacol"},{"key":"e_1_2_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197902000-00012"},{"key":"e_1_2_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.7.2235"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.22.7743"},{"key":"e_1_2_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/5.10.1275"},{"key":"e_1_2_2_22_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4049\/jimmunol.154.1.459","article-title":"Co\u2010infusion of normal bone marrow partially corrects the gld T\u2010cell defect: Evidence for an intrinsic and extrinsic role of Fas lignd","volume":"154","author":"Sobel ES","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90059-5"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.7.2260"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351116"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290912"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198608000-00002"},{"key":"e_1_2_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92177-7"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-341360-4.50185-2"},{"key":"e_1_2_2_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.146.1.34"},{"key":"e_1_2_2_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.10.5274"},{"key":"e_1_2_2_32_2","first-page":"85","article-title":"Treatment oflife threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation\u2014rationale and experimental backgroung","volume":"12","author":"Slavin S","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339300200304"},{"key":"e_1_2_2_34_2","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson R","year":"1992","journal-title":"J Rheumatol"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.1995.tb03649.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.1995.tb03649.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:34:30Z","timestamp":1695882870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.1995.tb03649.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.1111\/j.1365-3083.1995.tb03649.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.1995.tb03649.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}